Although biologics and immunosuppressants (TNF-α inhibitors, dupilumab, etc.)may be required for AD and/or psoriasis with significant severity, their long-term fetal safety is not well understood, and more investigation is needed for this population [76]. The gene discussed is TNF; the disease is psoriasis.